A high dose of Wegovy that helped people lose 21% of their weight in a clinical trial was just approved

Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.

​Novo Nordisk’s 7.2 mg dose of Wegovy will compete against Lilly’s GLP-1 injection.